Kisspeptin-54 (27-54) (human)

OC(C=C1)=CC=C1C[C@H](NC([C@H](CC(N)=O)NC([C@H]2N(CCC2)C([C@H](CC(C)C)NC([C@H](CC(O)=O)NC([C@H](CCCCN)NC([C@H](CCC(O)=O)NC([C@H](CCCNC(N)=N)NC([C@H](CCC(N)=O)NC([C@H](C(C)C)NC([C@H](CC(C)C)NC([C@H](C(C)C)NC([C@H](C)NC(CNC([C@H](CCC(N)=O)NC([C@H]3N(CCC3)C([C@H](C)NC([C@H]4N(CCC4)C([C@@H](N)[C@@H](C)CC)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)C(N[C@@H](CC(N)=O)C(N[C@H](C(N[C@@H](CC(N)=O)C(N[C@@H](CO)C(N[C@H](C(NCC(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(N)=O)CC5=CC=CC=C5)=O)=O)=O)=O)CC6=CC=CC=C6)=O)=O)=O)CC7=CNC8=CC=CC=C78)=O)=O

[1]Bevec D, et al. Therapeutic uses of urocortin ii and kisspeptin (27-54) . World Intellectual Property Organization. WO2009039984.|[2]Milton N, et al. Kisspeptin peptides for use in the treatment of Alzheimer's disease, Creutzfeldt-Jakob disease or diabetes mellitus. European Patent Organization. EP2388012.